IncFact
Company Profiles: Revenue, Growth, Competition

ALEXION PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Big Fish
Big Fish
 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Alexion Pharmaceuticals

Access the complete profile.

Alexion Pharmaceuticals Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325414 Biological Product Manufacturing
Address100 College St
New Haven, CT 06510

www.alexionpharm.com


Alexion Pharmaceuticals's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Alexion Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Alexion Pharmaceuticals is a publicly traded company on NASDAQ using the ticker symbol ALXN. Detailed information on company financials and operating reports can be found here: NASDAQ: ALXN



Alexion Pharmaceuticals Annual Revenue and Growth Rate

Alexion Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Alexion Pharmaceuticals's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Alexion Pharmaceuticals is developing and marketing. Alexion Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
UMEZIRIS
Pharmaceutical preparations
07/13/2018
EVIMIRIS
Pharmaceutical preparations
07/13/2018
UMEBIRIS
Pharmaceutical preparations
07/13/2018

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Alexion Pharmaceuticals's intellectual property, its current capabilities and future direction. Alexion Pharmaceuticals has applied for 92 patents since 2009. Alexion Pharmaceuticals's most recent patent was filed in September 2018 for Methods Of Producing Anti-c5a Antibodies. The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement-associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospho lipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Alexion Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Alexion Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Alexion Pharmaceuticals vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Alexion Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SYNEOS HEALTHRaleigh, NC100 
ALEXION PHARMACEUTICALSNew Haven, CT88 
LEIDOS HOLDINGSReston, VA79 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM59 




Nearby Competitors

These companies are similar in business line and location to Alexion Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ALEXION PHARMACEUTICALSNew Haven, CT100 
MELINTA THERAPEUTICS INC. /NEW/New Haven, CT2 
MOLECULAR NEUROIMAGINGNew Haven, CT1 
HASKINS LABORATORIESNew Haven, CT0 
PROMETHEUS RESEARCHNew Haven, CT0 
JOHN B. PIERCE LABORATORYNew Haven, CT0 




Similar Sized Companies near New Haven

These are similar in size and location to Alexion Pharmaceuticals.

Company HeadquartersRevenue ($ MM)
YALE NEW HAVEN HOSPITALNew Haven, CT100 
ASSA ABLOYNew Haven, CT80 
KNIGHTS OF COLUMBUS COMMINGLED FUNDS LLC - KNIGHTS OF COLUMBUS GLOBAL REAL ESTATE FUNDNew Haven, CT65 
CONNECTICUT CARPENTERS HEALTH FUNDHamden, CT57 
YALE UNIVERSITYNew Haven, CT54 
CONNECTICUT LABORERS' HEALTH FUNDWest Haven, CT29 




Fastest Growing Competitors

These companies are in the same general field as Alexion Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Alexion Pharmaceuticals Competitors